# Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder

> **NCT07477990** · PHASE3 · RECRUITING · sponsor: **Psicofarma, S.A. De C.V.** · enrollment: 162 (estimated)

## Conditions studied

- General Anxiety Disorder

## Interventions

- **OTHER:** App AURORA (Digital Therapy) + conventional treatment
- **DRUG:** Pharmacological conventional treatment

## Key facts

- **NCT ID:** NCT07477990
- **Lead sponsor:** Psicofarma, S.A. De C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-29
- **Primary completion:** 2027-06-29
- **Final completion:** 2027-07-01
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07477990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07477990, "Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07477990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*